↓ Skip to main content

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide

Overview of attention for article published in Investigational New Drugs, June 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
3 patents

Readers on

mendeley
18 Mendeley